Cetera Investment Advisers Reduces Position in Prestige Consumer Healthcare Inc. $PBH

Cetera Investment Advisers decreased its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 3.7% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,093 shares of the company’s stock after selling 196 shares during the quarter. Cetera Investment Advisers’ holdings in Prestige Consumer Healthcare were worth $438,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the business. Kayne Anderson Rudnick Investment Management LLC purchased a new stake in shares of Prestige Consumer Healthcare in the fourth quarter valued at about $84,932,000. BNP Paribas Financial Markets grew its holdings in shares of Prestige Consumer Healthcare by 1,073.3% in the fourth quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company’s stock valued at $15,923,000 after purchasing an additional 186,524 shares during the period. GAMMA Investing LLC grew its holdings in shares of Prestige Consumer Healthcare by 11,580.3% in the first quarter. GAMMA Investing LLC now owns 161,538 shares of the company’s stock valued at $13,887,000 after purchasing an additional 160,155 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Prestige Consumer Healthcare in the fourth quarter valued at about $7,778,000. Finally, Congress Asset Management Co. grew its holdings in shares of Prestige Consumer Healthcare by 9.1% in the first quarter. Congress Asset Management Co. now owns 991,580 shares of the company’s stock valued at $85,246,000 after purchasing an additional 82,838 shares during the period. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. Wall Street Zen lowered shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a “hold” rating in a report on Thursday, May 8th. Finally, Canaccord Genuity Group decreased their target price on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a “buy” rating on the stock in a research report on Friday, August 8th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $93.33.

Prestige Consumer Healthcare Trading Up 0.7%

NYSE PBH opened at $65.06 on Monday. The firm’s 50-day moving average is $77.27 and its two-hundred day moving average is $81.62. Prestige Consumer Healthcare Inc. has a 12 month low of $62.95 and a 12 month high of $90.04. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.38 and a quick ratio of 2.99. The stock has a market capitalization of $3.20 billion, a P/E ratio of 15.27, a PEG ratio of 2.05 and a beta of 0.43.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.95 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by ($0.06). The business had revenue of $249.53 million for the quarter, compared to analyst estimates of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%. The firm’s revenue for the quarter was down 6.6% compared to the same quarter last year. During the same period in the prior year, the company posted $0.90 EPS. On average, sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.